The group's principal activity is to develop therapeutic vaccines for the detection and prevention of food contaminating pathogens, veterinary diseases, and diseases affecting human health. The group publishes a news catalog to market its products, which includes family health news containing articles on health, nutrition, lifestyle and innovative health products and therapies. The products cater to agriculture, veterinary and health care industries. On 23-Mar-2003, the group acquired genethera, inc.
